Its not ethical to conduct medication trials on pregnant humans, so researchers rely on animal models and observational data from accidental exposures
Main conclusions: Efficiency: Ozempic shows impressive results in weight loss, especially in patients with obesity and type 2 diabetes
For cardiovascular protection, semaglutide wins
In people, this hormone helps regulate blood sugar, slows digestion, and reduces appetite often leading to significant weight loss.In fact, according to a Guardian report, in the United States, a pilot study is testing GLP-1 drugs a category that includes Wegovy, Mounjaro, and Ozempic on cats.Given how widespread obesity has become among pets with some studies estimating up to 65% of dogs in the UK are overweight or obese the idea of using a drug to curb appetite and make pets slimmer has fueled interest among pet parents and biotech firms.In fact, a startup has reportedly begun early trials of a modified GLP-1 treatment for cats, under a project nicknamed MEOW-1, standing for ManagEment of Over Weight cats. According to a Guardian article, there are an estimated 54,500 diabetic cats in the UK, many of them already enduring a treatment consisting of twice-daily injections of insulin
Too cold can be just as important as too warm
The Decisive Difference Is Regulatory Status, Not the Molecule If you remember one thing from this comparison, make it this: the molecules differ, but the regulatory status is what should reshape how you source